Treating shock - Old drugs, new ideas

New England Journal of Medicine

Volumn 362, Issue 9, 2010, Pages 841-843

  Levy, Jerrold H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPAMINE; HYPERTENSIVE FACTOR; NORADRENALIN; VASOPRESSIN; VASOCONSTRICTOR AGENT;

ACIDOSIS; ANAPHYLAXIS; CLINICAL TRIAL; EDITORIAL; HUMAN; HYPERGLYCEMIA; HYPOTENSION; PRIORITY JOURNAL; RESUSCITATION; SHOCK; CHEMICALLY INDUCED DISORDER; FLUID THERAPY; HEART ARRHYTHMIA; MORTALITY; MULTIMODALITY CANCER THERAPY; NOTE;

ARRHYTHMIAS, CARDIAC; COMBINED MODALITY THERAPY; DOPAMINE; FLUID THERAPY; HUMANS; NOREPINEPHRINE; SHOCK; VASOCONSTRICTOR AGENTS;

EID: 77649313883     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1000091     Document Type: Editorial

References (10)

1. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
2. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110(9):e82-e292.
3. Port JD, Gilbert EM, Larrabee P, et al. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart. Circulation 1990;81:929-38.
4. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001;345:588-95.
5. Levy JH, Adkinson NF Jr. Anaphylaxis during cardiac surgery: implications for clinicians. Anesth Analg 2008;106:392-403.
6. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010;362:779-89.
7. Sakr Y, Reinhart K, Vincent JL, et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006;34:589-97.
8. Patel GP, Grahe JS, Sperry M, et al. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock 2009 October 21 (Epub ahead of print).
9. Albanèse J, Leone M, Garnier F, Bourgoin A, Antonini F, Martin C. Renal effects of norepinephrine in septic and nonseptic patients. Chest 2004;126:534-9.
10. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-87.